Kallikrein gene downregulation in breast cancer

British Journal of Cancer

Volumn 90, Issue 1, 2004, Pages 167-172

  Yousef, G M ^a,b   Yacoub, G M ^c   Polymeris, M E ^b   Popalis, C ^b   Soosaipillai, A ^a   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COMPARATIVE STUDY; DATA BASE; DIFFERENTIAL DISPLAY; DNA LIBRARY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING;

BLOTTING, NORTHERN; BREAST NEOPLASMS; DATABASES, NUCLEIC ACID; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0842265103     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601451     Document Type: Article

References (44)

1. Adams MD, Soares MB, Kerlavage AR, Fields C, Venter JC (1993) Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat Genet 4: 373-380
2. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R (1996) A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 2: 624-636
3. Barry MJ (2001) Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 344: 1373-1377
4. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA, Wheeler DL (2002) GenBank. Nucleic Acids Res 30: 17-20
5. Black MH, Diamandis EP (2000) The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 59: 1-14
6. Brattsand M, Egelrud T (1999) Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274: 30033-30040
7. Clements J, Hooper J, Dong Y, Harvey T (2001) The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol Chem 382: 5-14
8. Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, Band V (2001) Analysis of normal epithelial cell specific-1 (NES1)/Kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 7: 3393-3398
9. Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D (2003) Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol 21: 1035-1043
10. Diamandis EP, Yousef GM (2001) Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn 1: 182-190
11. Diamandis EP, Yousef GM (2002) Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 48: 1198-1205
12. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P (2000a) Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem 33: 579-583
13. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G (2000b) Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem 33: 369-375
14. Fortier AH, Nelson BJ, Grella DK, Holaday JW (1999) Antiangiogenic activity of prostate-specific antigen. J Natl Cancer Inst 91: 1635-1640
15. Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, Moss P, Paeper B, Wang K (2000) Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257: 119-130
16. Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V (1998) The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 58: 4782-4786
17. Lai LC, Erbas H, Lennard TW, Peaston RT (1996) Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743-746
18. Lercher MJ, Urrutia AO, Hurst LD (2002) Clustering of housekeeping genes provides a unified model of gene order in the human genome. Nat Genet 31: 180-183
19. Liu XL, Wazer DE, Watanabe K, Band V (1996) Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res 56: 3371-3379
20. Luo L, Bunting P, Scorilas A, Diamandis EP (2001a) Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin Chim Acta 306: 111-118
21. Luo LY, Grass L, Howarth DJ, Thibault P, Ong H, Diamandis EP (2001b) Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin Chem 47: 237-246
22. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, Van Gramberen M, De Bruijn H, Henrik A, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Diamandis EP (2003) The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res 63: 807-811
23. Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP (2001c) Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br J Cancer 85: 220-224
24. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S (1999) Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 59: 5464-5470
25. Seth P, Porter D, Lahti-Domenici J, Geng Y, Richardson A, Polyak K (2002) Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res 62: 4540-4544
26. Strausberg RL (2001) The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer. J Pathol 195: 31-40
27. Strausberg RL, Greenhut SF, Grouse LH, Schaefer CF, Buetow KH (2001) In silico analysis of cancer through the Cancer Genome Anatomy Project. Trends Cell Biol 11: S66-S71
28. Tanimoto H, Underwood LJ, Shigemasa K, Yan Yan MS, Clarke J, Parmley TH, O'Brien TJ (1999) The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly over-expressed in ovarian tumor cells. Cancer 86: 2074-2082
29. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995) Serial analysis of gene expression. Science 270: 484-487
30. Yoshida S, Taniguchi M, Suemoto T, Oka T, He X, Shiosaka S (1998) cDNA cloning and expression of a novel serine protease, TLSP. Biochim Biophys Acta 1399: 225-228
31. Yousef GM, Chang A, Diamandis EP (2000a) Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem 275: 11891-11898
32. Yousef GM, Diamandis EP (1999) The new kallikrein-like gene, KLK-L2 Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem 274: 37511-37516
33. Yousef GM, Diamandis EP (2000) The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65: 184-194
34. Yousef GM, Diamandis EP (2001) The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22: 184-204
35. Yousef GM, Diamandis EP (2002a) Expanded human tissue kallikrein family - a novel panel of cancer biomarkers. Tumour Biol 23: 185-192
36. Yousef GM, Diamandis EP (2002b) Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem 383: 1045-1057
37. Yousef GM, Diamandis EP (2003) Human kallikreins: common structural features, sequence analysis and evolution. Curr Genom 4: 147-165
38. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP (2001) Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res 61: 3425-3431
39. Yousef GM, Magklara A, Diamandis EP (2000b) KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics 69: 331-341
40. Yousef GM, Polymeris ME, Grass L, Soosaipillai A, Chan PC, Scorilas A, Borgono C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP (2003) Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res 63: 3958-3965
41. Yousef GM, Scorilas A, Diamandis EP (2000c) Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics 63: 88-96
42. Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP (2002) Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 48: 1241-1250
43. Yousef GM, Scorilas A, Magklara A, Soosaipillai A, Diamandis EP (2000d) The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family -genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254: 119-128
44. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P (1995) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110